scid mice naturally infected with Pneumocystis carinii and inoculated with a normally apathogenic pneumovirus had significantly higher P. carinii cyst counts and developed significantly more severe P.
Pneumocystis carinii is clinically important in immunosuppressed individuals and is the most frequent opportunist and leading cause of death among AIDS patients (9) . P. carinii pneumonia also occurs in immunodeficient animals, including athymic rodents and rodents with severe combined immunodeficiency (5, 8, 10) , causing high morbidity and eventual mortality. An exacerbating or contributing viral effect on the expression of P. carinii pneumonia is suspected in humans and animals but has not been extensively studied. Some evidence suggests that the corticosteroid-treated-rat model of P. carinii infection relies on concurrent or prior infection with naturally occurring rodent viruses (1) . We have recently shown that pneumonia virus of mice (PVM), a normally apathogenic pneumovirus distantly related to respiratory syncytial virus (2), exacerbates pneumonia in P. carinii-infected C3H/HeSnJ scid mice (6) . However, those studies did not define the relative contribution of each agent to the pathogenesis of the resulting pneumonia. The current studies were undertaken to confirm and extend the prior finding and to study the pathogenesis of the disease.
Seventy-two C3H/HeSnJ (C3H) scid mice, 26 C3H congenic +/+ mice, 42 BALB/cByJ (BALB) scid mice and 36 BALB congenic +/+ mice from The Jackson Laboratory (Bar Harbor, Maine), and 10 P. carinii-free C.B-17/lcrT acfDF (C.B-17) scid mice (histocompatible with BALB mice) and 4 P. carinii-free C.B-17 congenic +/+ mice from Taconic Laboratory Animals and Services (Germantown, N.Y.) were used at 2 to 3 months of age. They were housed in sterile Micro-Barrier (Allentown Caging, Allentown, N.J.) or Micro-Isolator (Lab Products, Maywood, N.J.) cages that were manipulated within a class II biological safety cabinet.
Mice were inoculated intranasally with 1,000 fluorescentfocus units (FFU) of PVM (12) the right anterior, middle, and posterior lung lobes and from corresponding areas of the left lung. Lungs were paraffin embedded, and 5-,um sections were mounted on 3-aminopropyltriethoxysilane-coated glass slides. Six sections per mouse were stained with each of the following: hematoxylin and eosin, avidin-biotin complex immunoperoxidase (12) to visualize PVM antigen, and Grocott's silver stain (7) to visualize P. carinii cysts. All slides were coded and evaluated blindly. Lesion severity scores were assigned by the method of Walzer et al. (11) , viral antigen was quantified by the method of Reid (4), and P. caninii cyst counts were performed by the method of Roths et al. (5) . Infectious PVM in accessory lung lobes was detected and quantified as previously described (12) , and virus titers, expressed as FFU per gram, were calculated by the method of Lorenz and Bogel (3) . Parametric data were analyzed by Student's two-tailed t test, and nonparametric data were analyzed by the Mann-Whitney U test.
Ruffled fur, dehydration, dyspnea, and death were observed only in PVM-inoculated (P. carinii-infected) C3H scid and BALB scid mice beginning on day 27. Lungs from C3H scid mice necropsied on days 10, 15, 20, 25, and 28 after virus inoculation and BALB scid mice necropsied on days 10, 20, and 28 showed similar trends, with progressively more severe lesions and more severe disease in virusinfected than in sham-inoculated scid mice (Fig. 1A and C) . Microscopic evaluation of lungs from both sham-and virusinoculated scid mice revealed alveolar septae that were thickened by infiltrating macrophages, alveoli and alveolar septae that contained sparse polymorphonuclear leukocytes, and moderate peribronchiolar accumulations of mononuclear leukocytes. Intra-alveolar macrophages with vesiculated or foamy cytoplasm and extracellular eosinophilic material, typical of P. carinii infection, were also seen. Virus-infected scid mice also had prominent perivascular and peribronchiolar infiltration of mononuclear leukocytes, and alveolar lumina contained exfoliated pneumocytes, macrophages, lymphoid cells, polymorphonuclear leukocytes, and occasionally erythrocytes. By day 28, some PVMinoculated scid mice had consolidation that involved more than 50% of the lung mass.
In both PVM-inoculated and sham-inoculated scid mice, cyst densities increased with time ( Fig. 1B and D (Fig. 2) .
Virus titers in the lungs of PVM-inoculated C3H scid mice In contrast to scid mice that were P. carinii infected at the time of virus inoculation, P. carinii-free C.B-17 scid mice developed only subtle clinical signs (slightly ruffled fur) at 58 days after virus infection. Microscopic lesions were widespread in lungs of virus-infected C.B-17 scid mice at this interval but were mild relative to those seen in lungs of P. carinii-infected C3H scid and BALB scid mice. The lesion severity scores were 0.0 0.0 for sham-inoculated C.B-17 scid mice (n = 5) and 2.8 0.5 for virus-infected C.B-17 scid mice (n = 5; P < 0.01). Lungs of PVM-inoculated, P. carinii-free C.B-17 scid mice contained twice as much viral antigen at day 58 as did lungs of virus-infected C3H scid or BALB scid mice at day 28 (Table 1) , and the mean virus titer in lungs of PVM-inoculated C.B-17 scid mice (n = 5) was 5.2 ± 0.9 log1o FFU/g.
Prior studies of PVM-associated exacerbation of P. carinii disease (6) had been done with C3H scid mice. The current study extends that finding to BALB scid mice. The development of significant differences in lesion severity and cyst density between sham-and PVM-inoculated scid mice of either strain occurred rapidly and quite late in the course of disease. Despite high pulmonary virus titers, PVM-infected C.B-17 scid mice that were P. carinii free were also clinically normal at 1 month and survived twice as long as virusinoculated, P. carinii-infected C3H scid and BALB scid mice. Colocalization of P. carinii cysts and PVM antigen was not observed in lungs of C3H scid mice, suggesting that exacerbation was due not to direct interaction of the two agents but possibly to interaction via host cells and/or cytokines. However, the possibility of an unseen direct effect does exist because cysts, not trophozoites, were stained.
One goal of these studies was to determine the cause of disease and death in dually infected C3H scid and BALB scid mice. The relatively low virus titers and very high cyst densities in the lungs of mice of both strains at 28 days, combined with the results obtained with P. carinii-free C.B-17 scid mice, strongly suggest that disease and death were due to exacerbation of P. carinii pneumonia.
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